Home

Myriam Curet

CIK 1632901 · EVP & Chief Medical Officer · last filed 2026-08-03

Myriam Curet is an EVP & Chief Medical Officer who has filed 152 SEC Form 4 insider transactions across 5 companies since 2015. The most recent filing, for MOBI, was dated Aug 3, 2026. Across all open-market trades the lifetime net is −$89.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.4M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.38M

Companies

5

Total Filings

152

Lifetime Open-Market Net

-$89.35M

Filer Profile

Reported Address
1020 KIFER ROAD
SUNNYVALE, CA 94086
Phone
(408) 523-7587
State of Incorporation
DE
Formerly Known As
Myriam Curet (2015–2021)
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MOBI Director — $10.01 — $0 1 2026-08-03
STXS Director 435,161 $1.29 $561.4K $0 10 2026-07-01
INSP Director 6,927 $73.00 $505.7K $188 5 2026-05-04
ISRG EVP & Chief Medical Officer 514 $369.15 $189.7K -$89.24M 100 2026-03-11
NKTR Director 1,828 $69.76 $127.5K -$109.2K 8 2023-09-20

Recent Filings

152 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-03 MOBI Grant (A) — $0 EDGAR
2026-07-01 STXS Grant (A) +43,103 $0 EDGAR
2026-05-04 INSP Grant (A) +3,562 $0 EDGAR
2026-04-27 ISRG Notice (144) −30,417 -$14.32M EDGAR
2026-03-11 ISRG Mixed — -$27.8K EDGAR
2026-03-10 ISRG Notice (144) −105 -$51.9K EDGAR
2026-03-03 ISRG Notice (144) −4,728 -$2.30M EDGAR
2026-03-03 ISRG Mixed −4,728 -$2.34M EDGAR
2026-03-02 ISRG Notice (144) −125 -$61.6K EDGAR
2026-03-02 ISRG Mixed +2,383 -$3.51M EDGAR
Showing 1–10 of 152
Page 1 of 16
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.